Ardent Health Partners (NYSE:ARDT - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.31, Zacks reports. The business had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.48 billion. Ardent Health Partners updated its FY 2025 guidance to 1.730-2.010 EPS.
Ardent Health Partners Price Performance
NYSE ARDT traded down $0.50 on Friday, reaching $14.66. The company had a trading volume of 726,478 shares, compared to its average volume of 396,256. The company's fifty day moving average is $15.20 and its 200 day moving average is $16.83. Ardent Health Partners has a 52-week low of $13.55 and a 52-week high of $20.72. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78.
Analyst Ratings Changes
Several equities analysts have recently weighed in on the stock. JPMorgan Chase & Co. reiterated a "neutral" rating and set a $20.00 price objective on shares of Ardent Health Partners in a report on Tuesday, December 17th. Royal Bank of Canada reiterated an "outperform" rating and set a $23.00 price objective on shares of Ardent Health Partners in a report on Thursday, November 14th. Morgan Stanley lowered their target price on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 21st. Stephens reaffirmed an "overweight" rating and set a $22.00 target price on shares of Ardent Health Partners in a research report on Thursday. Finally, Bank of America lowered Ardent Health Partners from a "buy" rating to a "neutral" rating and lowered their target price for the stock from $22.00 to $19.00 in a research report on Wednesday, November 6th. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of $21.36.
View Our Latest Report on Ardent Health Partners
About Ardent Health Partners
(
Get Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Featured Stories
Before you consider Ardent Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.
While Ardent Health Partners currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.